retatrutide clinical trial results weight loss 2024 2025 press release Lilly's triple agonist, retatrutide, delivered powerful in pivotal Phase 3 obesity Lilly's triple-acting obesity drug hits
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2





























